This inventor holds 1 USPTO granted patent. Top assignees: The University of Mississippi, University of Michigan. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 158 
1 out of 3,536 
Years Active: 2025
Title: Michael A Puskarich: Innovator in Sepsis Treatment
Introduction
Michael A Puskarich is a notable inventor based in Jackson, MS (US). He has made significant contributions to the field of medicine, particularly in the treatment of septic shock. His innovative approach focuses on identifying patients who are most likely to benefit from L-carnitine treatment.
Latest Patents
Puskarich holds a patent titled "Serum metabolites as biomarkers for carnitine treatment of sepsis." This technology relates to methods and systems for identifying sepsis patients who would benefit from L-carnitine treatment. His work is crucial in improving patient outcomes in critical care settings.
Career Highlights
Throughout his career, Puskarich has worked at prestigious institutions such as the University of Michigan and the University of Mississippi. His experience in these academic environments has allowed him to advance his research and contribute to the medical community.
Collaborations
One of his notable collaborators is Alan E Jones. Their partnership has likely fostered innovative ideas and advancements in their shared field of research.
Conclusion
Michael A Puskarich's contributions to the treatment of sepsis through innovative patent technology highlight his role as a significant figure in medical research. His work continues to impact the lives of patients facing critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile